journal article·2016-05-11

High Antimicrobial Activity and Low Human Cell Cytotoxicity of Core–Shell Magnetic Nanoparticles Functionalized with an Antimicrobial Peptide

Hajar Maleki, Akhilesh Rai, Sandra Pinto, Marta Evangelista, Renato M.S. Cardoso, Cristiana Paulo, Tiago Carvalheiro, Artur Paiva, Mohammad Imani, Abdolreza Simchi, Luísa Durães, António Portugal, Lino Ferreira

Publisher page

Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with antimicrobial agents are promising infection-targeted therapeutic platforms when coupled with external magnetic stimuli. These antimicrobial nanoparticles (NPs) may offer advantages in fighting intracellular pathogens as well as biomaterial-associated infections. This requires the development of NPs with high antimicrobial activity without interfering with the biology of mammalian cells. Here, we report the preparation of biocompatible antimicrobial SPION@gold core-shell NPs based on covalent immobilization of the antimicrobial peptide (AMP) cecropin melittin (CM) (the conjugate is named AMP-NP). The minimal inhibitory concentration (MIC) of the AMP-NP for Escherichia coli was 0.4 μg/mL, 10-times lower than the MIC of soluble CM. The antimicrobial activity of CM depends on the length of the spacer between the CM and the NP. AMP-NPs are taken up by endothelial (between 60 and 170 pg of NPs per cell) and macrophage (between 18 and 36 pg of NPs per cell) cells and accumulate preferentially in endolysosomes. These NPs have no significant cytotoxic and pro-inflammatory activities for concentrations up to 200 μg/mL (at least 100 times higher than the MIC of soluble CM). Our results in membrane models suggest that the selectivity of AMP-NPs for bacteria and not eukaryotic membranes is due to their membrane compositions. The AMP-NPs developed here open new opportunities for infection-site targeting.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Bacteriophages and microbial interactions · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CIEPQPF, Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal

Biocant-Biotechnology Innovation Center, 3060-197 Cantanhede, Portugal

CNC-Center of Neurosciences and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal

Blood and Transplantation Center of Coimbra, Portuguese Institute of Blood and Transplantation, 3041-861 Coimbra, Portugal

Novel Drug Delivery Systems Department, Iran Polymer and Petrochemical Institute, 13115-14977 Tehran, Iran

Department of Material Science and Engineering, Sharif University of Technology, 11365-11155 Tehran, Iran

Institute for Nanoscience and Nanotechnology, Sharif University of Technology, 11365-11155 Tehran, Iran

Funding

Funda??o para a Ci?ncia e a Tecnologia · European Regional Development Fund

References (43)

Show source-provided references
1. 10.2147/IJN.S2728510.2147/IJN.S27285 ↗
2. 10.1016/j.jconrel.2007.10.02710.1016/j.jconrel.2007.10.027 ↗
3. 10.1126/scitranslmed.300452810.1126/scitranslmed.3004528 ↗
4. 10.2147/IJN.S597610.2147/IJN.S5976 ↗
5. 10.1016/j.actbio.2012.03.00210.1016/j.actbio.2012.03.002 ↗
6. 10.1038/nbt126710.1038/nbt1267 ↗
7. 10.1073/pnas.92.8.344910.1073/pnas.92.8.3449 ↗
8. 10.1016/S0006-3495(04)74108-910.1016/S0006-3495(04)74108-9 ↗
9. 10.1016/j.jmmm.2012.06.04510.1016/j.jmmm.2012.06.045 ↗
10. 10.1016/0003-2697(79)90790-510.1016/0003-2697(79)90790-5 ↗
11. 10.1021/bc050091v10.1021/bc050091v ↗
12. 10.1016/j.addr.2007.10.00510.1016/j.addr.2007.10.005 ↗
13. 10.1111/j.1365-2818.2006.01706.x10.1111/j.1365-2818.2006.01706.x ↗
14. 10.1016/j.matchemphys.2015.07.01810.1016/j.matchemphys.2015.07.018 ↗
15. 10.1021/ja050432f10.1021/ja050432f ↗
16. 10.1016/j.jmmm.2011.08.03510.1016/j.jmmm.2011.08.035 ↗
17. 10.1039/C4RA09341K10.1039/C4RA09341K ↗
18. 10.1007/s11671-009-9298-610.1007/s11671-009-9298-6 ↗
19. 10.1039/c0nr00621a10.1039/c0nr00621a ↗
20. 10.1039/b402823f10.1039/b402823f ↗
21. 10.1021/nl035253f10.1021/nl035253f ↗
22. 10.1021/ja053659j10.1021/ja053659j ↗
23. 10.1021/cm049586510.1021/cm0495865 ↗
24. 10.1021/jz101202a10.1021/jz101202a ↗
25. 10.1021/ja027470910.1021/ja0274709 ↗
26. 10.1016/S0014-5793(99)01600-210.1016/S0014-5793(99)01600-2 ↗
27. 10.1006/bbrc.1998.911410.1006/bbrc.1998.9114 ↗
28. Ferreira, L.; Langer, R. S.; Loose, C. R.; O’Shaughnessy, W. S.; Stephanopolous, G.; Zumbuehl, A.Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides. Patent WO2007095393 A2, 2007.
29. 10.1378/chest.118.1.14610.1378/chest.118.1.146 ↗
30. 10.1038/292246a010.1038/292246a0 ↗
31. 10.1038/nnano.2011.5810.1038/nnano.2011.58 ↗
32. 10.1093/eurheartj/ehs36610.1093/eurheartj/ehs366 ↗
33. 10.1016/j.addr.2006.09.01310.1016/j.addr.2006.09.013 ↗
34. Hopp L. · Perspect. Respir. Nurs. · 1995 · 6 · 8
35. 10.1073/pnas.090446510610.1073/pnas.0904465106 ↗
36. 10.1016/j.biomaterials.2007.11.01810.1016/j.biomaterials.2007.11.018 ↗
37. 10.1016/S1748-0132(07)70084-110.1016/S1748-0132(07)70084-1 ↗
38. 10.1016/0005-2736(89)90226-510.1016/0005-2736(89)90226-5 ↗
39. 10.1074/jbc.M50704220010.1074/jbc.M507042200 ↗
40. 10.1016/j.bbamem.2012.07.02110.1016/j.bbamem.2012.07.021 ↗
41. 10.1021/bi00010a03410.1021/bi00010a034 ↗
42. 10.1016/0005-2736(84)90152-410.1016/0005-2736(84)90152-4 ↗
43. 10.1248/cpb.54.8010.1248/cpb.54.80 ↗